Generation Bio Co. (GBIO)
Generation Bio Statistics
Share Statistics
Generation Bio has 67.04M shares outstanding. The number of shares has increased by 0.72% in one year.
| 67.04M |
| 0.72% |
| 0.32% |
| 80.69% |
| n/a |
| 4,477 |
| 0.9% |
Short Selling Information
The latest short interest is 1.89M, so 2.82% of the outstanding shares have been sold short.
| 1.89M |
| 2.82% |
| 4.11% |
| 3.21 |
Valuation Ratios
The PE ratio is -0.54 and the forward PE ratio is -0.36. Generation Bio's PEG ratio is -0.53.
| -0.54 |
| -0.36 |
| 3.55 |
| 0.5 |
| 0.82 |
| -0.78 |
| -0.53 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Generation Bio.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 5.5, with a Debt / Equity ratio of 1.09.
| 5.5 |
| 5.5 |
| 1.09 |
| -1.26 |
| -1.03 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $172,973.91 |
| $-1,144,939.13 |
| 115 |
| 0.09 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -88.86% in the last 52 weeks. The beta is 2.66, so Generation Bio's price volatility has been higher than the market average.
| 2.66 |
| -88.86% |
| 0.39 |
| 1.25 |
| 42.69 |
| 497,647 |
Income Statement
In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -1.98.
| 19.89M |
| 19.89M |
| -142.39M |
| -131.67M |
| -74.26M |
| -79.19M |
| -1.98 |
Balance Sheet
The company has 76.3M in cash and 93.56M in debt, giving a net cash position of -17.26M.
| 76.3M |
| 93.56M |
| -17.26M |
| -703.04M |
| 201.35M |
| 145.52M |
Cash Flow
In the last 12 months, operating cash flow was -88.56M and capital expenditures -2.4M, giving a free cash flow of -90.96M.
| -88.56M |
| -2.4M |
| -90.96M |
| -1.37 |
Margins
Gross margin is 100%, with operating and profit margins of -715.82% and -661.91%.
| 100% |
| -715.82% |
| -661.91% |
| -661.91% |
| -373.33% |
| -715.82% |
| -457.29% |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for GBIO is $8, which is 2062.2% higher than the current price. The consensus rating is "Buy".
| $8 |
| 2062.2% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -5.1 |
| 2 |